G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/30/2004	US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004	US6824773 TWEAK receptor
11/30/2004	US6824755 Method for producing a catalyst support and compositions thereof
11/30/2004	US6824670 Biosensor system which quantitates the concentration of glucose, cholesterol, etc in blood by measuring electric current
11/30/2004	US6824669 Monitoring interaction with immobilized probe without requiring use of reporter molecules
11/30/2004	US6824656 Interdigitated electrochemical gas generator
11/30/2004	US6824513 Device, method and use of an odor detection unit for examining and/or recording
11/30/2004	US6823750 Method of preventing short sampling of a capillary or wicking fill device
11/30/2004	US6823727 Device having a sensor arrangement for determining the ambient-air quality and an arrangement of ozone sensors upstream and downstream of a radiator which is coated with a catalyst material, and method for operating a device of this type
11/30/2004	US6823721 Solids and liquids in a clarification system at various points in a drilling mud treatment system used with a drilling rig; graphically display the fractional or absolute quantities of the constituents of drilling mud
11/30/2004	US6823717 Hybrid microcantilever sensors
11/30/2004	CA2468118A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering rna precursors enabling the formation and function of small interfering rna in vivo and in vitro
11/30/2004	CA2377813C Extracellular recording multiple electrode
11/30/2004	CA2362117C A system for cell-based screening
11/30/2004	CA2319252C Circulating insulin-like growth factor-i and prostate cancer risk
11/30/2004	CA2310912C Ultrasonic seafood probe
11/30/2004	CA2272890C Non-aggregated fluorescent conjugates and method for obtaining them
11/30/2004	CA2263082C Thin absorbent article
11/30/2004	CA2240471C Method for testing a cell sample
11/30/2004	CA2240158C Method for simultaneous analysis of cell viability, nucleated red blood cells and white blood cell differential
11/30/2004	CA2198957C Method for the detection of creatinine
11/30/2004	CA2175483C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
11/30/2004	CA2171872C Method, reagent and kit for the detection of fecal occult blood
11/30/2004	CA2148166C Ion mobility spectrometer
11/30/2004	CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/29/2004	CA2468472A1 Test sensor and method for manufacturing the same
11/29/2004	CA2468290A1 Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
11/27/2004	CA2463585A1 Method of and apparatus for measuring mercury contained in gaseous medium
11/25/2004	WO2004102215A1 Assay for testing neurotoxin vaccine efficacy
11/25/2004	WO2004102202A1 Activation mixture
11/25/2004	WO2004102201A1 Gain of function sorting for drug discovery and development
11/25/2004	WO2004102200A1 Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
11/25/2004	WO2004102199A2 Method for selecting and producing vaccine components and vaccines based thereon
11/25/2004	WO2004102198A2 Selection of b cells with specificity of interest: method of preparation and use
11/25/2004	WO2004102196A1 Apparatus including nanostructures used for separation or analysis, and the preparation and application thereof
11/25/2004	WO2004102195A1 Method for identifying tff2 regulating agents and agents identified using said method
11/25/2004	WO2004102194A1 Support having selectively bonding substance fixed thereto
11/25/2004	WO2004102193A2 Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers
11/25/2004	WO2004102192A1 A non-invasive assay for the assessment of functioning and/or structure of the gut
11/25/2004	WO2004102191A2 Serum protein profiling for the diagnosis of epithelial cancers
11/25/2004	WO2004102190A1 Differential diagnosis of colorectal cancer and other diseases of the colon
11/25/2004	WO2004102189A1 Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer
11/25/2004	WO2004102188A1 Methods and applications of biomarker profiles in the diagnosis and treatment of breast cancer
11/25/2004	WO2004102187A1 Apparatus and method for measuring moisture content in concrete
11/25/2004	WO2004102185A1 Indicator
11/25/2004	WO2004102184A1 Compositions and methods for concentrating polypeptides and proteins
11/25/2004	WO2004102183A2 An apparatus for analysing fluid taken from a body
11/25/2004	WO2004102181A2 Determination of aromatic hydrocarbons in edible oil products
11/25/2004	WO2004102165A1 Multiplexed multitarget screening method
11/25/2004	WO2004102160A2 Imaging platform for nanoparticle detection applied to spr biomolecular interaction analysis
11/25/2004	WO2004102159A2 Quantum mechanics based method for scoring protein-ligand interactions
11/25/2004	WO2004102157A2 Improved methods for protein interaction determination
11/25/2004	WO2004102156A2 Compositional modeling and pyrolysis data analysis methods
11/25/2004	WO2004102154A2 Systems and methods for measuring fluid properties
11/25/2004	WO2004102152A2 Improved porous device
11/25/2004	WO2004101824A1 Method of detecting chronic obstructive pulmonary disease
11/25/2004	WO2004101823A1 Nucleic acid array comprising abasic sites
11/25/2004	WO2004101814A1 Diagnostics and therapeutics for diseases associated with x-pro dipeptidase like peptidase (pepdlike)
11/25/2004	WO2004101813A1 Diagnostics and therapeutics for diseases associated with kell blood group antigen (kel)
11/25/2004	WO2004101807A2 High troughput monitoring chamber for testing drug effects on repolarization and conduction
11/25/2004	WO2004101782A1 Method of judging efficacy of therapy against hepatitis c virus
11/25/2004	WO2004101780A2 Heparanase-derived peptides for vaccination of tumor patients
11/25/2004	WO2004101779A2 Functional characterization of myo-inositol monophosphatase
11/25/2004	WO2004101772A2 Neural cells
11/25/2004	WO2004101769A2 Proteins, sensors, and methods of characterizing analytes using the same
11/25/2004	WO2004101762A2 Detection and treatment of cancers of the colon
11/25/2004	WO2004101761A2 METHODS FOR THE IDENTIFICATION OF INHIBITORS OF CAX1-LIKE Ca+2/H+ANTIPORTER ACTIVITY IN PLANTS
11/25/2004	WO2004101758A2 Composition for maintaining organ and cell viability
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101745A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB
11/25/2004	WO2004101743A2 Three dimensional cell cultures in a microscale fluid handling system
11/25/2004	WO2004101738A2 Domain-exchanged binding molecules, methods of use and methods of production
11/25/2004	WO2004101730A1 Microparticle based biochip systems and uses thereof
11/25/2004	WO2004101616A1 LIVER X RECEPTOR α SPLICING MUTANT PROTEIN, GENE THEREOF AND UTILIZATION OF THE SAME
11/25/2004	WO2004101130A2 System, method, and product for providing a wavelength-tunable excitation beam
11/25/2004	WO2004101072A1 Cns chloride modulation and uses thereof
11/25/2004	WO2004100990A1 Apoptosis inducer for cancer cell
11/25/2004	WO2004100980A1 Interferon for treating or preventing a coronaviral infection
11/25/2004	WO2004100977A1 Inhibition of tumor cell proliferation by foxm1b inhibitors
11/25/2004	WO2004100974A1 USE OF Hab 18G/CD 147 MOLECULE AS TARGET OF ANTIVIRAL ANTAGONIST AND THUS OBTAINED ANTIVIRAL ANTAGONIST
11/25/2004	WO2004100971A1 Compositions and methods for controlling insects
11/25/2004	WO2004100890A2 Rage g82s-related methods and compositions for treating inflammatory disorders
11/25/2004	WO2004100773A2 Diagnostic and therapeutic treatments related to mitochondrial disorders
11/25/2004	WO2004100760A1 Predicting cancer progression
11/25/2004	WO2004100759A2 Endo 180 receptor for diagnosis and treatment
11/25/2004	WO2004095221A3 Apparatus and methods for analyzing and characterizing nucleic acid sequences
11/25/2004	WO2004093662A3 Method for detecting prognosis of cancer
11/25/2004	WO2004091637A3 System capable of treating and defining various diseases using stem cells
11/25/2004	WO2004088307A3 Detection method for the expression of recombinant proteins on a cell surface and for the immobilization and purification of cells and proteins
11/25/2004	WO2004088276A3 A method and kit for detecting the early onset of renal tubular cell injury
11/25/2004	WO2004087965A3 Statistical analysis of regulatory factor binding sites of differentially expressed genes
11/25/2004	WO2004085611A3 Model for mutually exclusive domain folding molecular switch
11/25/2004	WO2004078123A3 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
11/25/2004	WO2004074842A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 (prostaglandin e2 ep3)
11/25/2004	WO2004072277A3 Elk1 phosphorylation related genes
11/25/2004	WO2004070057A3 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome
11/25/2004	WO2004065959A3 Kinases and gpcrs involved in apoptosis
11/25/2004	WO2004065129A3 Electrochemical sensor having improved response time
11/25/2004	WO2004062462A3 Monclonal anitbodies to rna binding protein gw182
11/25/2004	WO2004061458A3 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease

1 ... 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 ... 3937